You are here

Lupin sets off Indian pharma's long road to redemption

Hit by bans and sanctions, Indian drugmakers work overtime to satisfy FDA on hygiene, safety standards

BT_20170710_CPPHARM10_2973459.jpg
Lupin is phasing out the practice of making notes in hardbound registers by workers as it transitions to more secure e-files. It also videotapes staff to ensure they follow standard operating procedure.

Goa

IN 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier. Most of the last six months on his desk calendar is marked green, indicating visits to the 12 plants of Lupin, India's No 2 drugmaker, where Mr Desai is a senior quality control executive. Only one day

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom